Precision BioSciences to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

DURHAM, N.C., Nov. 24, 2020 - Precision BioSciences, Inc. (Nasdaq: DTIL) announced that its Chief Scientific Officer, Derek Jantz, Ph.D., will participate in a fireside chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference taking place from November 30 to December 3, 2020. The chat has been pre-recorded and is accessible to registered attendees via the Piper Sandler conference site until December 3. It can also be found on Precision's official website in the Investors and Media section.

DURHAM, N.C., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS^® genome editing platform, today announced that its Chief Scientific Officer, Derek Jantz, Ph.D., will participate in a fireside chat at the Piper Sandler 32^nd Annual Virtual Healthcare Conference, November 30 – December 3, 2020.

This fireside chat has been pre-recorded and is now available for registered attendees via the Piper Sandler conference site until December 3. It is also available on Precision's website, www.PrecisionBiosciences.com in the Investors and Media section under Events and Presentations.

About Precision BioSciences, Inc.
Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its novel and proprietary ARCUS^® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple "off-the-shelf" CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist. For more information about Precision BioSciences please visit www.precisionbiosciences.com.

Investor Contact:
Alex Kelly
Chief Corporate Affairs Officer
Alex.Kelly@precisionbiosciences.com

FAQ

What is the date of the Piper Sandler 32nd Annual Virtual Healthcare Conference for DTIL?

The Piper Sandler 32nd Annual Virtual Healthcare Conference takes place from November 30 to December 3, 2020.

Who will represent Precision BioSciences at the Piper Sandler conference?

Derek Jantz, Ph.D., the Chief Scientific Officer, will represent Precision BioSciences.

Where can I watch the fireside chat for DTIL?

The fireside chat is available on the Piper Sandler conference site for registered attendees and on Precision BioSciences' official website.

What does Precision BioSciences focus on?

Precision BioSciences focuses on improving life through its ARCUS® genome editing platform, with various clinical candidates in its pipeline.